313 related articles for article (PubMed ID: 16166615)
1. Proteomic analysis of sputum from adults and children with cystic fibrosis and from control subjects.
Sloane AJ; Lindner RA; Prasad SS; Sebastian LT; Pedersen SK; Robinson M; Bye PT; Nielson DW; Harry JL
Am J Respir Crit Care Med; 2005 Dec; 172(11):1416-26. PubMed ID: 16166615
[TBL] [Abstract][Full Text] [Related]
2. Glycosylation of sputum mucins is altered in cystic fibrosis patients.
Schulz BL; Sloane AJ; Robinson LJ; Prasad SS; Lindner RA; Robinson M; Bye PT; Nielson DW; Harry JL; Packer NH; Karlsson NG
Glycobiology; 2007 Jul; 17(7):698-712. PubMed ID: 17392389
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary function is negatively correlated with sputum inflammatory markers and cough clearability in subjects with cystic fibrosis but not those with chronic bronchitis.
Kim JS; Okamoto K; Rubin BK
Chest; 2006 May; 129(5):1148-54. PubMed ID: 16685004
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress and lipid-derived inflammatory mediators during acute exacerbations of cystic fibrosis.
Reid DW; Misso N; Aggarwal S; Thompson PJ; Walters EH
Respirology; 2007 Jan; 12(1):63-9. PubMed ID: 17207027
[TBL] [Abstract][Full Text] [Related]
5. Sputum club cell protein concentration is associated with pulmonary exacerbation in cystic fibrosis.
Laguna TA; Williams CB; Brandy KR; Welchlin-Bradford C; Moen CE; Reilly CS; Wendt CH
J Cyst Fibros; 2015 May; 14(3):334-40. PubMed ID: 25456770
[TBL] [Abstract][Full Text] [Related]
6. Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis.
de Boer K; Vandemheen KL; Tullis E; Doucette S; Fergusson D; Freitag A; Paterson N; Jackson M; Lougheed MD; Kumar V; Aaron SD
Thorax; 2011 Aug; 66(8):680-5. PubMed ID: 21680566
[TBL] [Abstract][Full Text] [Related]
7. Sputum and serum calprotectin are useful biomarkers during CF exacerbation.
Gray RD; Imrie M; Boyd AC; Porteous D; Innes JA; Greening AP
J Cyst Fibros; 2010 May; 9(3):193-8. PubMed ID: 20299288
[TBL] [Abstract][Full Text] [Related]
8. Induced sputum matrix metalloproteinase-9 correlates with lung function and airway inflammation in children with cystic fibrosis.
Sagel SD; Kapsner RK; Osberg I
Pediatr Pulmonol; 2005 Mar; 39(3):224-32. PubMed ID: 15635615
[TBL] [Abstract][Full Text] [Related]
9. Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis.
Waters V; Stanojevic S; Atenafu EG; Lu A; Yau Y; Tullis E; Ratjen F
Eur Respir J; 2012 Jul; 40(1):61-6. PubMed ID: 22135280
[TBL] [Abstract][Full Text] [Related]
10. Induced sputum inflammatory measures correlate with lung function in children with cystic fibrosis.
Sagel SD; Sontag MK; Wagener JS; Kapsner RK; Osberg I; Accurso FJ
J Pediatr; 2002 Dec; 141(6):811-7. PubMed ID: 12461498
[TBL] [Abstract][Full Text] [Related]
11. A novel neutrophil derived inflammatory biomarker of pulmonary exacerbation in cystic fibrosis.
Reeves EP; Bergin DA; Fitzgerald S; Hayes E; Keenan J; Henry M; Meleady P; Vega-Carrascal I; Murray MA; Low TB; McCarthy C; O'Brien E; Clynes M; Gunaratnam C; McElvaney NG
J Cyst Fibros; 2012 Mar; 11(2):100-7. PubMed ID: 22035905
[TBL] [Abstract][Full Text] [Related]
12. MUC5AC and MUC5B mucins increase in cystic fibrosis airway secretions during pulmonary exacerbation.
Henke MO; John G; Germann M; Lindemann H; Rubin BK
Am J Respir Crit Care Med; 2007 Apr; 175(8):816-21. PubMed ID: 17255563
[TBL] [Abstract][Full Text] [Related]
13. Nebulized hypertonic saline decreases IL-8 in sputum of patients with cystic fibrosis.
Reeves EP; Williamson M; O'Neill SJ; Greally P; McElvaney NG
Am J Respir Crit Care Med; 2011 Jun; 183(11):1517-23. PubMed ID: 21330456
[TBL] [Abstract][Full Text] [Related]
14. Chronic Stenotrophomonas maltophilia infection and exacerbation outcomes in cystic fibrosis.
Waters V; Atenafu EG; Salazar JG; Lu A; Yau Y; Matukas L; Tullis E; Ratjen F
J Cyst Fibros; 2012 Jan; 11(1):8-13. PubMed ID: 21849265
[TBL] [Abstract][Full Text] [Related]
15. Production of the potent neutrophil chemokine, growth-related protein alpha (GROalpha), is not elevated in cystic fibrosis children.
Wyatt HA; Sampson AP; Balfour-Lynn IM; Price JF
Respir Med; 2000 Feb; 94(2):106-11. PubMed ID: 10714414
[TBL] [Abstract][Full Text] [Related]
16. Association between pulmonary function and sputum biomarkers in cystic fibrosis.
Mayer-Hamblett N; Aitken ML; Accurso FJ; Kronmal RA; Konstan MW; Burns JL; Sagel SD; Ramsey BW
Am J Respir Crit Care Med; 2007 Apr; 175(8):822-8. PubMed ID: 17234902
[TBL] [Abstract][Full Text] [Related]
17. Lung function in infants with cystic fibrosis diagnosed by newborn screening.
Linnane BM; Hall GL; Nolan G; Brennan S; Stick SM; Sly PD; Robertson CF; Robinson PJ; Franklin PJ; Turner SW; Ranganathan SC;
Am J Respir Crit Care Med; 2008 Dec; 178(12):1238-44. PubMed ID: 18787217
[TBL] [Abstract][Full Text] [Related]
18. Lipoxin A(4) and interleukin-8 levels in cystic fibrosis sputum after antibiotherapy.
Chiron R; Grumbach YY; Quynh NV; Verriere V; Urbach V
J Cyst Fibros; 2008 Nov; 7(6):463-8. PubMed ID: 18541460
[TBL] [Abstract][Full Text] [Related]
19. Association between inflammatory markers in induced sputum and clinical characteristics in children with non-cystic fibrosis bronchiectasis.
Guran T; Ersu R; Karadag B; Akpinar IN; Demirel GY; Hekim N; Dagli E
Pediatr Pulmonol; 2007 Apr; 42(4):362-9. PubMed ID: 17351928
[TBL] [Abstract][Full Text] [Related]
20. The impact of treatment of pulmonary exacerbations on the health-related quality of life of patients with cystic fibrosis: does hospitalization make a difference?
Yi MS; Tsevat J; Wilmott RW; Kotagal UR; Britto MT
J Pediatr; 2004 Jun; 144(6):711-8. PubMed ID: 15192614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
